PTC Therapeutics (PTCT) Reports Q3 Loss of $0.19

November 14, 2013 7:31 AM EST Send to a Friend

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($0.19) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

PTC Therapeutics (PTCT) Reports Q3 Loss of $0.19

Member Login

Free News Feed